Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease
Home | Video pages | Webcast | The role of complement in glomerulonephritis: are novel therapies ready for prime time?
Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease
Approaching the patient with CKD and comorbidities associated: how to choose the right treatment?